Premium
Current use of 18 F‐Fluorodeoxyglucose Positron Emission Tomography and Combined Positron Emission Tomography and Computed Tomography in Squamous Cell Carcinoma of the Head and Neck
Author(s) -
Zimmer Lee A.,
Branstetter Barton F.,
Nayak Jayakar V.,
Johnson Jonas T.
Publication year - 2005
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1097/01.mlg.0000181495.94611.a6
Subject(s) - positron emission tomography , medicine , magnetic resonance imaging , head and neck cancer , positron emission , head and neck squamous cell carcinoma , radiology , tomography , nuclear medicine , preclinical imaging , fluorodeoxyglucose , positron emission tomography computed tomography , head and neck , radiation therapy , surgery , microbiology and biotechnology , biology , in vivo
The history and physical examination, computed tomography (CT) and magnetic resonance imaging are the cornerstones for identifying new and recurrent cancers of the head and neck. The advent of positron emission tomography (PET) and combined PET/CT imaging technology is a promising development. These modalities have the potential to help stage patients presenting with head and neck cancer, identify responses to nonsurgical therapy, and allow earlier detection of recurrence in the hope of improving survival. The following paper provides a brief history of PET and PET/CT imaging. The current PET and PET/CT literature for squamous cell carcinoma of the head and neck is reviewed, and specific recommendations for its use are provided.